Intermediate for Tofacitinib. Tofacitinib (trade name Xeljanz, Jakvinus) is a janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib has been approved by the U.S Food and Drug Administration in November 2012.
Product Name: 7H-Pyrrolo[2,3-d]pyrimidin-4-ol
CAS Number: 3680-71-5
Molecular Weight:  135.125
Molecular Formula:  C6H5N3O
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.